Clinical practice guidelines for the management of adult diffuse gliomas

Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China), Chinese Brain Cancer Association (CBCA), Chinese Glioma Genome Atlas (CGGA), Asian Glioma Genome Atlas (AGGA) network

Research output: Contribution to journalReview articlepeer-review

Abstract

To follow the revision of the fourth edition of WHO classification and the recent progress on the management of diffuse gliomas, the joint guideline committee of Chinese Glioma Cooperative Group (CGCG), Society for Neuro‐Oncology of China (SNO-China) and Chinese Brain Cancer Association (CBCA) updated the clinical practice guideline. It provides recommendations for diagnostic and management decisions, and for limiting unnecessary treatments and cost. The recommendations focus on molecular and pathological diagnostics, and the main treatment modalities of surgery, radiotherapy, and chemotherapy. In this guideline, we also integrated the results of some clinical trials of immune therapies and target therapies, which we think are ongoing future directions. The guideline should serve as an application for all professionals involved in the management of patients with adult diffuse glioma and also a source of knowledge for insurance companies and other institutions involved in the cost regulation of cancer care in China and other countries.

Original languageEnglish
Pages (from-to)60-72
Number of pages13
JournalCancer Letters
Volume499
DOIs
StatePublished - 28 Feb 2021
Externally publishedYes

Keywords

  • Chemoradiation
  • Immune therapy
  • Molecular diagnostics
  • Surgery
  • Target therapy

Fingerprint

Dive into the research topics of 'Clinical practice guidelines for the management of adult diffuse gliomas'. Together they form a unique fingerprint.

Cite this